Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Jul 20, 2016, 12:12 ET Was unterstüzt den Antrieb von rapider Innovation, nahtlosem Wachstum und IP-Wertsteigerung in 2016?

Der IP Life Sciences Exchange hat den Bericht "Unter dem Mikroskop" zusammengestellt, um die wichtigsten Fragen zu erforschen, die sich den...


Jul 20, 2016, 11:59 ET Elusys Therapeutics Announces That Manuscripts For Its Anthrax Antitoxin, ANTHIM® (obiltoxaximab) Injection, Have Been Accepted For Publication

Elusys Therapeutics, Inc. (Elusys) today announced that two important manuscripts describing animal efficacy of ANTHIM (obiltoxaximab) Injection...


Jul 20, 2016, 11:18 ET CSL Plasma Raises Over $118,000 For The Immune Deficiency Foundation

CSL Plasma Inc., one of the world's largest collectors of human plasma, has set a new giving record for their donation to the Immune Deficiency...


Jul 20, 2016, 11:03 ET Mylan Launches Generic Crestor® Tablets

 Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Rosuvastatin Calcium Tablets, 5 mg, 10 mg, 20 mg and 40 mg, which is a...


Jul 20, 2016, 10:12 ET Strategic Relationship with Redox to Expand EHR Integration Capabilities

 ImpediMed Limited (ASX: IPD) announced today a partnership with Redox to expand the capabilities of electronic health record (EHR)...


Jul 20, 2016, 09:56 ET Dragonfly anuncia su Consejo Asesor Científico

Importante compañía de inmunoterapia lanza su Consejo Asesor Científico con el nombramiento del ganador del Premio Nobel Harold...


Jul 20, 2016, 09:00 ET EpiBiome Accepted into Stanford's StartX Accelerator Program

EpiBiome, a precision microbiome engineering company working to curb the growing threat of multi-drug-resistant "superbugs" by eliminating the use...


Jul 20, 2016, 08:30 ET Worldwide Clinical Trials Survey Reveals How Sponsors View the Role of CROs in Clinical Development

A recent survey by Worldwide Clinical Trials reveals that 62 percent of respondents are more likely to engage a clinical research organization...


Jul 20, 2016, 08:30 ET Biohaven commences clinical testing of BHV-4157

TORONTO, July 20, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U),...


Jul 20, 2016, 08:30 ET Luminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time

Luminex Corporation (NASDAQ: LMNX) today announced that it will now hold a conference call to discuss the second quarter operating highlights and...


Jul 20, 2016, 08:28 ET Das HIV Global Access Programm von Roche wird um die nächste Generation automatisierter Plattformlösungen erweitert

Die cobas® Systeme mit hohem Durchsatz unterstützen die Optimierung des Arbeitsflusses in Umgebungen mit beschränkten Ressourcen...


Jul 20, 2016, 08:00 ET PhaseRx Appoints Gordon Brandt, M.D. as Chief Medical Officer

 PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing mRNA products to correct life-threatening inherited liver diseases in...


Jul 20, 2016, 08:00 ET The ALS Association and ALS Finding a Cure Announce Joint Funding Support for Amylyx Clinical Trial of AMX0035 for the Treatment of ALS

The ALS Association and Amylyx Pharmaceuticals based in Cambridge, Mass. are pleased to announce that The ALS Association and ALS Finding a...


Jul 20, 2016, 07:56 ET Le Programme d'accès mondial Roche HIV s'élargit afin d'inclure les solutions de plate-forme automatisées de prochaine génération

  Les systèmes cobas® à haut débit contribuent à optimiser le flux de travail pour les milieux aux ressources...


Jul 20, 2016, 07:40 ET Technical Coverage on Biotechnology Equities -- Galena Biopharma, Eleven Biotherapeutics, Relypsa, and Amgen

The Biotech arena continues to grapple with research and development costs, drug approvals, and high medicine prices. Additionally, the upcoming...


Jul 20, 2016, 07:30 ET NVIDIA Partners with SMI to Demo Foveated Rendering for VR at Siggraph 2016

SMI Eye Tracking with low latency and high frame rate key to success of innovative rendering technique Computer graphics giant NVIDIA has chosen...


Jul 20, 2016, 06:00 ET ContraVir Pharmaceuticals to Present at 41st Annual International Herpesvirus Workshop

 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted...


Jul 20, 2016, 06:00 ET Caprion Biosciences Acquired by GHO Capital

 Caprion Biosciences announced today that the company has been recapitalized and acquired by GHO Capital, the European specialist investor in...


Jul 20, 2016, 05:24 ET Dragonfly gibt seinen wissenschaftlichen Beirat bekannt

Das bahnbrechende Immuntherapieunternehmen kündigt die Gründung seines wissenschaftlichen Beirates mit der Ernennung des...


Jul 20, 2016, 04:00 ET Chronos Therapeutics Acquires Pre-clinical Programmes From Shire

Expands Pipeline With Novel CNS Assets in a Transformative Deal Chronos Therapeutics Ltd (Chronos), the private biotech company focused on...


Jul 20, 2016, 03:30 ET What's Helping Drive Rapid Innovation, Seamless Growth and Increased Value in IP in 2016

The IP Life Sciences Exchange put together the report "Under the Microscope" to explore the most pressing issues facing in-house counsel in the...


Jul 20, 2016, 00:00 ET Synthorx Announces $10 Million Series B Financing to Develop and Scale Novel Protein Therapeutics with Improved Pharmacological Properties

 Synthorx Inc. announced today the completion of a $10 million Series B financing, led by RA Capital Management and joined by Series A...


Jul 19, 2016, 21:18 ET Audentes Therapeutics Announces Pricing of Initial Public Offering

Audentes Therapeutics, Inc., a biotechnology company focused on developing and commercializing gene therapy products for patients suffering from...


Jul 19, 2016, 18:04 ET Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain

Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that the U.S....


Jul 19, 2016, 17:29 ET Dragonfly Announces Its Scientific Advisory Board

Dragonfly Therapeutics, Inc. ("Dragonfly"), co-founded in July 2015 by Dr. Tyler Jacks of the Massachusetts Institute of Technology, Dr. David...